Covid vaccine from Germany’s CureVac just 48% effective
The company in part blames 'the unprecedented context of 15 strains circulating' among the trial volunteers, as well as varying responses across age groups.
Poor interim trial results for Germany’s CureVac jab
CVnCoV was shown to be just 47% effective in an interim analysis of its late-stage trial.